Oncopharmpod

Fruquintinib And Osimertinib-Chemo in Combo?

Informações:

Synopsis

This week's Pod dives into a new VEGF-R inhibitor, fruquintinib. We also ask if FLAURA2, osimertinib + chemotherapy in combination, will become a new standard of care in EGFR-mutated metastatic NSCLC.